HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel insertion mutation in the PLA2G6 gene in an Iranian family with infantile neuroaxonal dystrophy.

AbstractBACKGROUND:
Infantile neuroaxonal dystrophy is an autosomal recessive neurological disorder. Individuals with infantile neuroaxonal dystrophy experience progressive loss of vision, mental skills and muscular control, and other variable clinical signs. Pathogenic variants in the PLA2G6 gene, encoding phospholipase A2, are recognized to be the fundamental reason for infantile neuroaxonal dystrophy. This study aimed to detect pathogenic variant in a consanguine Iranian family with infantile neuroaxonal dystrophy.
METHODS:
The mutation screening was done by whole exome sequencing followed by direct Sanger sequencing.
RESULTS:
We identified a homozygous insertion mutation, NM_003560: c.1548_1549insCG (p.G517Rfs*29) in exon 10 of PLA2G6 in the patient. The parents were heterozygous for variant.
CONCLUSIONS:
Because of the clinical heterogeneity and rarity of infantile neuroaxonal dystrophy, whole exome sequencing is critical to confirm the diagnosis and is an excellent tool for INAD management.
AuthorsDorsa Rostampour, Mohammad Reza Zolfaghari, Milad Gholami
JournalJournal of clinical laboratory analysis (J Clin Lab Anal) Vol. 36 Issue 3 Pg. e24253 (Mar 2022) ISSN: 1098-2825 [Electronic] United States
PMID35092705 (Publication Type: Journal Article)
Copyright© 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
Chemical References
  • Group VI Phospholipases A2
  • PLA2G6 protein, human
Topics
  • Group VI Phospholipases A2 (genetics)
  • Homozygote
  • Humans
  • Iran
  • Mutagenesis, Insertional
  • Mutation (genetics)
  • Neuroaxonal Dystrophies (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: